The recommended dose is one to two drops of Betaxolol Hydrochloride Ophthalmic Solution in the affected eye(s) twice daily. In some patients, the intraocular pressure lowering responses to Betaxolol Hydrochloride Ophthalmic Solution may require a few weeks to stabilize. As with any new medication, careful monitoring of patients is advised.
If the intraocular pressure of the patient is not adequately controlled on this regimen, concomitant therapy with pilocarpine and other miotics, and/or epinephrine and/or carbonic anhydrase inhibitors can be instituted.
Betaxolol Hydrochloride Ophthalmic Solution is a sterile, isotonic, aqueous solution of betaxolol hydrochloride. Supplied as follows: 5, 10 and 15 mL in plastic ophthalmic DROP-TAINER* dispensers.
5 mL: NDC 61314-245-01 15 mL: NDC 61314-245-02
10 mL: NDC 61314-245-03
STORAGE: Store at room temperature.
*DROP-TAINER is a registered trademark of Alcon Manufacturing, Ltd.
FALCON Pharmaceuticals, Ltd.
Fort Worth, Texas 76134
ALCON LABORATORIES, INC.
Fort Worth, Texas 76134 USA
Printed in USA
NDC 61314-4245-03 Rx Only
0.5% as base
10 mL Sterile
AFFILATE OF QUALITY RX
| BETAXOLOL HYDROCHLORIDE |
betaxolol hydrochloride solution/ drops
|Labeler — Falcon Pharmaceuticals, Ltd. (874345820)|
|Registrant — Alcon Laboratories, Inc. (008018525)|
|Alcon Laboratories, Inc.||008018525||MANUFACTURE|
Revised: 07/2011 Falcon Pharmaceuticals, Ltd.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.